Milestone Pharmaceuticals Inc.
MISTNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $110.19M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.71$3.06
- Volume (live)
- -
- Avg. volume (3M)
- 1.32M
Milestone Pharmaceuticals (MIST) Stock Price & Financial Analysis
Milestone Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.70 - $0.80 |
|---|---|
| 52-Week High | $3.06 |
| 52-Week Low | $0.71 |
| Open | $0.80 |
| Volume (last close) | 974.36K |
| Average Volume (3M) | 1.32M |
| Revenue (TTM) | 2.34M |
|---|---|
| Net Income (TTM) | -84.01M |
| Free Cash Flow (TTM) | -61.26M |
| EPS (TTM) | −$0.80 |
| Profit Margin | -3585.62% |
| Operating Margin | -3353.01% |
| Return on Equity (ROE) | -461.14% |
| Debt to Equity | 7.80 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 110.19M |
|---|---|
| Shares Outstanding | 138.69M |
| Price to Sales (P/S) | 47.03 |
| Price to Book (P/B) | 6.05 |
| EV/EBITDA | -1.10 |
| 50-Day MA | $0.99 |
|---|---|
| 200-Day MA | $1.45 |
| 1-Year Change | −59.05% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Milestone Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Milestone Pharmaceuticals (MIST) has a market capitalization of $110.19M. The stock trades at 47.0× sales. Over the trailing twelve months it lost $84.01M on revenue of $2.34M and burned $61.26M of free cash flow.
As of its latest reported balance sheet, it holds $169.73M in cash and securities against $142.02M of debt, a net cash position of $27.70M.
Milestone Pharmaceuticals does not currently pay a dividend.
The share price is down 59.0% over the past year. At $0.71 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.71 to $3.06, below its 200-day moving average of $1.45.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.50, 819.0% above the Oct 16, 2026 close.
Frequently Asked Questions About Milestone Pharmaceuticals
What is the current stock price for MIST?
As of the Oct 16, 2026 close, MIST stock trades at $0.71. The 52-week range is $0.71–$3.06, with a day range of $0.70–$0.80.
What is the P/E ratio for MIST?
The P/E ratio (Price-to-Earnings) for MIST is shown in the Key Statistics section. This valuation metric helps compare Milestone Pharmaceuticals Inc. to industry peers.
Does MIST pay dividends?
Milestone Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MIST?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for MIST is Buy. The average 12-month price target is $6.50, a 819.0% upside from the Oct 16, 2026 close of $0.71.
What is the market cap of MIST?
As of the Oct 16, 2026 close, Milestone Pharmaceuticals's market capitalization is $98.1M, classifying it as a micro-cap company. Milestone Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.